1. Bullen C. Impact of tobacco smoking and smoking cessation on cardiovascular risk and disease. Expert Rev Cardiovasc Ther 2008;6:883–895.
2. Centers for Disease Control and Prevention (CDC). Smoking-attributable mortality, years of potential life lost, and productivity losses--United States, 2000-2004. MMWR Morb Mortal Wkly Rep 2008;57:1226–1228.
3. He J, Vupputuri S, Allen K, et al. Passive smoking and the risk of coronary heart disease–-a meta-analysis of epidemiologic studies. N Engl J Med 1999;340:920–926.
5. Barnoya J, Glantz SA. Cardiovascular effects of secondhand smoke: nearly as large as smoking. Circulation 2005;111:2684–2698.
7. Kirtane AJ, Kelly CR. Clearing the air on the “smoker’s paradox”. J Am Coll Cardiol 2015;65:1116–1118.
9. Pollock JS, Hollenbeck RD, Wang L, Janz DR, Rice TW, McPherson JA. A history of smoking is associated with improved survival in patients treated with mild therapeutic hypothermia following cardiac arrest. Resuscitation 2014;85:99–103.
10. Angeja BG, Kermgard S, Chen MS, et al. The smoker’s paradox: insights from the angiographic substudies of the TIMI trials. J Thromb Thrombolysis 2002;13:133–139.
11. Gennaro G, Brener SJ, Redfors B, et al. Effect of smoking on infarct size and major adverse cardiac events in patients with large anterior ST-elevation myocardial infarction (from the INFUSE-AMI Trial). Am J Cardiol 2016;118:1097–1104.
12. Kim JH, Chae SC, Oh DJ, et al. Multicenter cohort study of acute myocardial infarction in Korea – Interim analysis of the Korea acute myocardial infarction registry-National Institutes of Health Registry. Circ J 2016;80:1427–1436.
13. Thygesen K, Alpert JS; White HD; Joint ESC/ACCF/AHA/WHF task force for the redefinition of myocardial infarction. Universal definition of myocardial infarction. Eur Heart J 2007;28:2525–2538.
14. Scanlon PJ, Faxon DP, Audet AM, et al. ACC/AHA guidelines for coronary angiography. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on Coronary Angiography). Developed in collaboration with the Society for Cardiac Angiography and Interventions. J Am Coll Cardiol 1999;33:1756–1824.
15. Kini AS. Coronary angiography, lesion classification and severity assessment. Cardiol Clin 2006;24:153–162.
16. Jeong MH. Can time delay be shortened in the treatment of acute myocardial infarction?: experience from Korea acute myocardial infarction registry. Kor J Med 2010;78:582–585.
17. Lee HO, Jang SJ, Kim IS, et al. Long-term clinical outcomes after primary percutaneous coronary intervention in patients with acute myocardial infarction-on the basis of 65 years. Kor Contents J 2014;14:251–261.
19. Kook HY, Jeong MH, Oh S, et al. Current trend of acute myocardial infarction in Korea (from the Korea acute myocardial infarction registry from 2006 to 2013). Am J Cardiol 2014;114:1817–1822.
20. DeGeare VS, Stone GW, Grines L, et al. Angiographic and clinical characteristics associated with increased in-hospital mortality in elderly patients with acute myocardial infarction undergoing percutaneous intervention (a pooled analysis of the primary angioplasty in myocardial infarction trials). Am J Cardiol 2000;86:30–34.
21. Kodaira M, Miyata H, Numasawa Y, et al. Effect of smoking status on clinical outcome and efficacy of clopidogrel in acute coronary syndrome. Circ J 2016;80:1590–1599.
22. Gerber Y, Rosen LJ, Goldbourt U, et al. Smoking status and long-term survival after first acute myocardial infarction a population-based cohort study. J Am Coll Cardiol 2009;54:2382–2387.
24. Naylor CD, Chen E. Population-wide mortality trends among patients hospitalized for acute myocardial infarction: the Ontario experience, 1981 to 1991. J Am Coll Cardiol 1994;24:1431–1438.
25. Kim SY, Han JY, Kim YJ, et al. Long term survival rate and prognostic factors of acute myocardial infarction. Korean Circ J 1999;29:14–21.
26. Chen KY, Rha SW, Li YJ, et al. ‘Smoker’s paradox’ in young patients with acute myocardial infarction. Clin Exp Pharmacol Physiol 2012;39:630–635.
27. Bae EH, Lim SY, Cho KY, et al. GFR and cardiovascular outcomes after acute myocardial infarction: results from the Korea acute myocardial infarction registry. Am J Kidney Dis 2012;59:795–802.
28. Choi JS, Kim CS, Bae EH, et al. Predicting outcomes after myocardial infarction by using the chronic kidney disease epidemiology collaboration equation in comparison with the modification of diet in renal disease study equation: results from the Korea acute myocardial infarction registry. Nephrol Dial Transplant 2012;27:3868–3874.
30. Zaret BL, Wackers FJ, Terrin ML, et al. Value of radionuclide rest and exercise left ventricular ejection fraction in assessing survival of patients after thrombolytic therapy for acute myocardial infarction: results of Thrombolysis In Myocardial Infarction (TIMI) phase Ⅱ study. The TIMI Study Group. J Am Coll Cardiol 1995;26:73–79.
31. Kontos MC, Jamal S, Tatum JL, Ornato JP, Jesse RL. Predictive power of systolic function and congestive heart failure in patients with patients admitted for chest pain without ST elevation in the troponin era. Am Heart J 2008;156:329–335.
32. Davies CH, Ormerod OJ. Failed coronary thrombolysis. Lancet 1998;351:1191–1196.